Navigation path

Nanomedicine

Nanomedicine – the promise

Diseases such as diabetes, cancer, multiple sclerosis and Alzheimer’s pose a tremendous challenge to modern medicine. Societies are ageing around the world, yet today's elders wish to remain active and healthy, and live useful lives for as long as possible. How can this contradiction be resolved?

Many in the medical world are examining the potential of nanomedicine. Nanomedicine, the application of nanotechnology to human healthcare, offers numerous potential pathways to improving medical diagnosis and therapy and even to regenerate tissues and organs. It holds out the possibility of personalised yet more affordable healthcare while at the same time offering an improved quality of life for everyone. Nanomedicine is also a strategic issue for the competitive position of the healthcare industry in Europe. During the first four Calls of EU Framework Programme 7 in the years 2007-2010, the NMP Progamme invested about 265 Million Euro in nanomedicine related research projects. This concerned especially the development of targeted nanopharmaceuticals and nanodiagnostics technologies, biomaterials for implants and regenerative medicine and the development of intelligent prostheses with neural interfaces that can provide sensing and be actuated by brain activity.

The European Technology Platform for Nanomedicine is an important industry-led forum that provides inputs for the research priorities to be addressed and gives advice on innovation related policy for the nanomedicine field. Its members are European organisations that are actively researching the field of nanomedicine and working together to define research priorities and identify the issues that are important to get research results to patients.

Tiny transporters

Finding the best way forward